Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001014108-22-000058
Filing Date
2022-02-14
Accepted
2022-02-14 16:24:48
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5940
  Complete submission text file 0001014108-22-000058.txt   7394
Mailing Address 22 EINSTEIN ST., 5TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 5TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Issuer) CIK: 0001739174 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address P.O. BOX 1860 BENTONVILLE AR 72712
Business Address
Walton Thomas Layton (Reporting) CIK: 0001840680 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38762 | Film No.: 22632673